Restore Mind Medicine

Outsized Executive Compensation Over the past two years, shareholders have watched the Company's share price plummet a shocking 95%, the worst of its peer group, while the Board has lavished itself and management with over $51M in compensation over the same time period. Mr. Barrow and Dr. Karlin sold their restricted stock units as they vested for over $700,000 in 2022 - all while continuing to emphasize their purported belief in the vision of Mind Med. Source: Company SEC Filings, Refinitiv Year 2021 2022 Price Decline -45% -89% Total Executive Compensation $35M $13.6M Barrow Compensation $11M $5M MindMed suffers from a severe pay for performance disconnect. 56

View entire presentation